We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
1176
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$190K 0.01%
+262
New +$281K
AU icon
1177
AngloGold Ashanti
AU
$39.4B
$189K 0.01%
23,147
-141,693
-86% -$1.05M
NMIH icon
1178
NMI Holdings
NMIH
$3.37B
$184K 0.01%
24,340
+14,303
+143% +$117K
AGTC
1179
DELISTED
Applied Genetic Technologies Corporation
AGTC
$183K 0.01%
+13,956
New +$232K
AORT icon
1180
Artivion
AORT
$1.34B
$181K 0.01%
18,675
+100
+0.5% +$1.04K
FNB icon
1181
FNB Corp
FNB
$6.76B
$180K 0.01%
+13,934
New +$186K
CSCD
1182
DELISTED
CASCADE MICROTECH, INC.
CSCD
$180K 0.01%
+12,734
New +$186K
TNAV
1183
DELISTED
Telenav Inc.
TNAV
$179K 0.01%
22,982
-12,039
-34% -$87.5K
FSTR icon
1184
Foster
FSTR
$421M
$177K 0.01%
14,495
+8,203
+130% +$183K
AVH
1185
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$176K 0.01%
37,155
+15,571
+72% +$114K
GNBC
1186
DELISTED
Green Bancorp, Inc
GNBC
$176K 0.01%
+15,405
New +$199K
LADR
1187
Ladder Capital
LADR
$1.24B
$175K 0.01%
+15,246
New +$193K
TKC icon
1188
Turkcell
TKC
$4.7B
$173K 0.01%
19,915
-5,600
-22% -$57.8K
FRP
1189
DELISTED
Fairpoint Communications, Inc.
FRP
$173K 0.01%
+11,244
New +$190K
LSCC icon
1190
Lattice Semiconductor
LSCC
$16B
$169K 0.01%
44,133
-65,900
-60% -$303K
MRNS
1191
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$169K 0.01%
5,081
+932
+22% +$52.6K
HRI icon
1192
Herc Holdings
HRI
$4.78B
$168K 0.01%
3,348
-51,382
-94% -$2.69M
BBVA icon
1193
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
$167K 0.01%
+20,799
New +$188K
ECYT
1194
DELISTED
Endocyte, Inc. Common Stock
ECYT
$167K 0.01%
36,571
+8,913
+32% +$46.6K
PLNR
1195
DELISTED
PLANAR SYSTEMS INC
PLNR
$166K 0.01%
28,758
-1,800
-6% -$9.05K
MPT
1196
Medical Properties Trust
MPT
$2.84B
$165K 0.01%
14,940
-59,500
-80% -$738K
MTOR
1197
DELISTED
MERITOR, Inc.
MTOR
$162K 0.01%
15,271
-11,433
-43% -$148K
SBCF icon
1198
Seacoast Banking Corp of Florida
SBCF
$3.32B
$160K 0.01%
+10,932
New +$168K
MRGE
1199
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$160K 0.01%
+22,618
New +$143K
PACD
1200
DELISTED
Pacific Drilling S A
PACD
$160K 0.01%
12,856
-170
-1% -$3.43K

Similar funds

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.